Corcept Therapeutics
CORT
CORT
198 hedge funds and large institutions have $1.77B invested in Corcept Therapeutics in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 70 increasing their positions, 75 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $1.94B → $1.77B (-$171M)
42% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 26
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
198
Holding in Top 10
1
Calls
$11.7M
Puts
$8.59M
Top Buyers
| 1 | +$15.3M | |
| 2 | +$12.3M | |
| 3 | +$10.3M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.95M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$2.76M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$9.05M | |
| 3 | -$9.03M | |
| 4 |
AWS
AJ Wealth Strategies
New York
|
-$5.95M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$5.73M |